Poseida Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of PSTX for the last quarter is 25.97 M USD, and it's 7.71% lower compared to the previous quarter. The net income of Q2 24 is -31.37 M USD.